CTOR Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Citius Oncology Inc

Watchlist Manager

Watchlist

Price: 0.7777 USD 3.69% Market Closed

Market Cap: $72.3m

C	Citius Oncology Inc NASDAQ:CTOR	US
	Alamo Group Inc NYSE:ALG	US
	Trucept Inc OTC:TREP	US
	Biomea Fusion Inc NASDAQ:BMEA	US
G	Goodtech ASA F:6FO	NO
	Nuo Therapeutics Inc OTC:AURX	US
	Wesco International Inc NYSE:WCC	US
	Gowing Bros Ltd ASX:GOW	AU
	Yellow Hat Ltd OTC:YLLWF	JP
I	India Cements Capital Ltd BSE:511355	IN
P	Perceptive Capital Solutions Corp NASDAQ:PCSC	US
	Technical Olympic SA F:TQZA	GR
	Invibes Advertising NV PAR:ALINV	BE
X	X5 Retail Group NV MOEX:FIVE	RU
N	NetApp Inc F:NTA	US

Profitability Summary

Citius Oncology Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

77%

Strong 3Y Average Gross Margin

79%

Negative Operating Margin

-641%

Negative 3Y Average Operating Margin

-661%

Negative Net Margin

-648%

Negative 3Y Average Net Margin

-668%

Negative Free Cash Flow Margin

-273%

Negative 3Y Average Free Cash Flow Margin

-299%

Negative ROE

-127%

Negative 3Y Average ROE

-95%

Negative ROIC

-53%

Negative 3Y Average ROIC

-45%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.